Halo !!! Saya Kang Ismet, ini adalah blog tentang AMP HTML dan cara penerapannya

Immunotherapy; Ovarian Cancer; Pancreatic Cancer; Prostate Cancer; Bladder Cancer; Disabled; Liver Cancer; Brain Tumours; Breast Cancer; End-of-Life

Latest news and research on all cancers and treatments, updated several times a week, plus 10,000-item data base of these
Here’s a Sample of My Raw Data -> In Excel -> Leaner (Excel) -> with dictionary


A novel phase 1 clinical trial that leverages T-cell immunotherapy is now under way at Karmanos Cancer Institute (KCI) in Detroit and Memorial ...

This trial forms the basis for the Gradalis personalized immunotherapy program. The ovarian cancer program is the first of several development ...

NewLink Genetics' proprietary cancer immunotherapy programs may prove to have broad potential across a spectrum of cancer indications. NewLink ...

BERKELEY, CA, USA I February 26, 2015 I Aduro Biotech, Inc. today announced the initiation of an investigator-sponsored Phase 2 clinical trial of the ...

HPV infections, in particular HPV16, are one of the major causes of this type of cancer. The immunotherapeutic is a conjugate of two HPV16 E6 ...

... a tumor, and nivolumab is designed to remove an immuno-suppressive mechanism that cancer cells have developed against the immune system.

 “Such activation of the immune system could in principle be applied for treatment of any type of cancer, and also in combination with other ...

These therapies include: the use of HIV to transform a patient's immune system into a cancer-killing machine; a genetically engineered cold virus ...

Tumours are a lot like earthquakes. No two are the same, and just as quakes occur mostly along fault lines, scientists have discovered that tumours ...

A new study suggests that a certain gene has the ability to influence the shape of normal pancreatic cells and as a result, can be the culprit for the ...

Currently just 1 per cent of all people with pancreatic cancer survive for ten years after diagnosis. Most die within weeks or months because symptoms ...

Researchers have found that pancreatic cancer can be split into four unique types, a discovery that could be used to improve treatments for the ...

Doctors at Global Hospitals here have successfully performed a laparoscopic surgery on a patient suffering from pancreatic cancer. Under normal ...

Higher-Risk Prostate Cancer on the Rise?
A large retrospective analysis suggests the number of patients diagnosed with intermediate- and high-risk prostate cancer has increased since 2011.


AR-V7 Biomarker Could Guide Treatment in mCRPC Patients
Levels of AR-V7 in metastatic castration-resistant prostate cancer patients could guide physicians to treat with either taxanes or enzalutamide/abiraterone.

The National Institute for Health and Care Excellence has published the first clinical guideline on bladder cancer in the hope of improving diagnosis ..

... the development of cancer immunotherapies, is today providing an update on its clinical program in non-muscle invasive bladder cancer (NMIBC) at ...



Science Daily Cancer News

Adults with intellectual and developmental disabilities are much less likely to be screened for colorectal cancer, research shows. "As individuals with intellectual and developmental disabilities live longer, their risk of developing chronic conditions like cancer increases. Suboptimal screening may contribute to a greater cancer burden in this population," says one researcher.

In a nested-case control study of individuals living in the UK, a part of the world with a relatively low incidence of liver cancer, statin use is associated with a decreased risk of liver cancer, according to a new study.

Glioblastomas are a highly aggressive type of brain tumor, with few effective treatment options. Researchers are one step closer to understanding glioblastoma development following the identification of a key protein signaling pathway involved in brain tumor stem cell growth and survival. Brain tumor stem cells are believed to play an important role in glioblastoma development and may be possible therapeutic targets.

Patients with larger malignant tumors of the breast who undergo chemotherapy before a breast cancer operation are more likely to opt for a breast-preserving procedure and forgo a mastectomy (surgical removal of the breast), according to a new study.

Emergency care providers vary in their understanding of a type of medical order intended to communicate seriously ill patients' choices for life-sustaining treatments, according to a pair of studies recently published.

About 15 percent of people with pancreatic cancer may benefit from therapy targeting a newly identified gene signature, scientists say. This sub-group of pancreatic cancer patients who possess a strong angiogenic gene signature could benefit from personalized therapies that cut off the pathways that feed the cancer's growth, they note.


One in every three women undergoing a mastectomy could potentially be spared chronic post-operative pain if anesthesiologists used a regional anesthetic technique in combination with standard care, according to a new study.